TC
PRVB

Trium Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Trium Capital’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-136,641
Closed -$3.29M – 101
2023
Q1 		$3.29M Buy
+136,641
New +$1.71M 1.14% 30

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Trium Capital's PRVB Position: Q2 2023 in Review

Trium Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 136,641 shares — an estimated $3.29M sold.

Trium Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $3.29M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • Trium Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Trium Capital sold 136,641 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $3.29M.
  • Trium Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Trium Capital's Provention Bio, Inc. Common Stock position peaked at $3.29M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Trium Capital's 13F filing for Q2 2023, filed 11 Aug 2023.